Bristol-Myers, AstraZeneca Type 2 diabetes pill gets first major approval, in European Union

PRINCETON, N.J. — Drugmakers Bristol-Myers Squibb Co. and AstraZeneca PLC say their experimental diabetes pill has gotten its first major approval, in the European Union.

Forxiga (for-SEE’-gah), a once-a-day pill for adult Type 2 diabetes patients, is the first drug approved in a new class called SGLT2 inhibitors.


Known chemically as dapagliflozin (da-pah-GLEH’-flo-zihn), Forxiga works independently of insulin to remove excess blood sugar from the body differently than other Type 2 diabetes drugs.


http://www.washingtonpost.com/business/bristol-myers-astrazeneca-type-2-diabetes-pill-gets-first-major-approval-in-european-union/2012/11/14/b8431c16-2e8d-11e2-b631-2aad9d9c73ac_story.html